FormattedPicture
View from the Top: Knud Vindfeldt, Head of Cultures & Enzymes, Chr. Hansen

March 2013
--- Knud Vindfeldt: “Chr. Hansen has a clear strategy to obtain EU approved health claims for our core probiotic strains. While the EFSA demands are high and timelines have been challenging, this does not change our strategy. To protect our customers and consumers from conflicting messages, we will only submit our applications for health claims when we are confident we have sufficient data to meet the EFSA requirements.”
PortraitPicture

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

20 Feb 2020 --- Tapping into the skin-gut axis, UK-based AxisBiotix, a subsidiary of SkinBioTherapeutics, has made an agreement with Dutch company Winclove Probiotics to develop... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

18 Feb 2020 --- Hum Nutrition has introduced its latest nutritional supplement called Private Party to help support vaginal microbiome health and prevent urinary tract infections... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

11 Feb 2020 --- Probi, a probiotic solutions company for the functional foods and healthcare industry, has released its fourth-quarter results to which the company reports stable... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

10 Feb 2020 --- Dairy that has been naturally modified to be lower in saturated fat can benefit blood cholesterol and heart health. This is according to a new study from the... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

10 Feb 2020 --- Gnosis by Lesaffre’s yeast strain ibSium (S.cerevisiae CNCM I-3856) can provide abdominal pain relief and improve bowel habits as well as stool... Read More

trans